Halucenex is a company focused on the development of life sciences, particularly in the exploration of new psychedelic compounds, the formulation and authorization of psychedelic compounds for both pharmaceutical and nutraceutical markets, and the implementation of clinical trials to assess the medical advantages of psychedelic medicine. In Windsor, Nova Scotia, Halucenex operates a 6000 sqft medical facility containing 6 treatment rooms and a secure laboratory exclusively dedicated to conducting psychedelic-assisted psychotherapy and clinical research.